A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing ...

A blood abnormality detected five decades ago has finally been solved, confirming the discovery of a new blood type.

Beam is pursuing a long-term, staged development strategy for sickle cell disease that includes three “waves” of ...

More Than 40 Adult Sickle Cell Disease Patients Now Enrolled in BEACON Trial of BEAM-101; Beam Expects to Dose 30 Patients and Present Updated ...

A new study has introduced an innovative approach to CAR-T therapy that could address some of the current challenges in ...

Patients undergoing a donor stem-cell transplant for leukemia or other blood-related cancer require months of specialized ...

The following is a summary of “Limited Benefit of Routine Clinical Follow-Up for Relapse Detection in Diffuse Large B-Cell ...

A team of researchers from the Translational Oncology Research Centre (TORC) of Vrije Universiteit Brussel (VUB), in ...

Preliminary fourth quarter 2024 total revenue of approximately $57.6 million which includes TAVALISSE® net product s ...

An antitumor biomedical cell product based on natural killer cells has been registered in Belarus. The technology was ...

FlowScore is a new, cost-effective metric for assessing red blood cell quality, improving oxygen delivery evaluation in blood ...